The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion (vol 31, pg 4279, 2012)

被引:7
|
作者
Jeong, K. J. [1 ]
Park, S. Y. [1 ]
Cho, K. H. [1 ]
Sohn, J. S. [2 ]
Lee, J. [3 ]
Kim, Y. K. [4 ]
Kang, J. [1 ]
Park, C. G. [1 ]
Han, J. W. [5 ]
Lee, H. Y. [1 ]
机构
[1] Konyang Univ, Coll Med, Myunggok Med Res Inst, Dept Pharmacol, Daejeon, South Korea
[2] Konyang Univ, Coll Med, Myunggok Med Res Inst, Dept Pathol, Daejeon, South Korea
[3] Konyang Univ, Coll Med, Myunggok Med Res Inst, Dept Microbiol, Daejeon, South Korea
[4] Sookmyung Womens Univ, Coll Pharm, Dept Pharmacol, Seoul, South Korea
[5] Sungkyunkwan Univ, Sch Pharm, Dept Biochem & Mol Biol, Suwon, South Korea
关键词
D O I
10.1038/s41388-019-0769-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The original version of this article contained an error in the published figures Fig 2 and Fig 3f, where the information was inadvertently duplicated. This error does not alter the conclusions of the paper. The corrected figures are published in this correction notice. The authors sincerely apologize for this error.
引用
收藏
页码:5108 / 5110
页数:3
相关论文
共 50 条
  • [1] The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion
    K J Jeong
    S Y Park
    K H Cho
    J S Sohn
    J Lee
    Y K Kim
    J Kang
    C G Park
    J W Han
    H Y Lee
    [J]. Oncogene, 2012, 31 : 4279 - 4289
  • [2] The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion
    Jeong, K. J.
    Park, S. Y.
    Cho, K. H.
    Sohn, J. S.
    Lee, J.
    Kim, Y. K.
    Kang, J.
    Park, C. G.
    Han, J. W.
    Lee, H. Y.
    [J]. ONCOGENE, 2012, 31 (39) : 4279 - 4289
  • [3] Correction: The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion
    K. J. Jeong
    S .Y. Park
    K. H. Cho
    J. S. Sohn
    J. Lee
    Y. K. Kim
    J. Kang
    C. G. Park
    J. W. Han
    H. Y. Lee
    [J]. Oncogene, 2019, 38 : 5108 - 5110
  • [4] Lysophosphatidic acid induces ovarian cancer cell invasion through EGFR phosphorylation and proteolytic enzyme expression
    Jeong, Kang Jin
    Cho, Kyung Hwa
    Kim, Jeong Jin
    Choi, Moon Jung
    Lee, Hol Young
    [J]. CANCER RESEARCH, 2013, 73
  • [5] Fasudil inhibits lysophosphatidic acid-induced invasion of ovarian cancer cells
    Ogata, Seiji
    Morishige, Ken-ichirou
    Sawada, Kenjirou
    Hashimoto, Kae
    Mabuchi, Seiji
    Kawase, Chiaki
    Sakata, Masahiro
    Kimura, Tadashi
    [J]. MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3495S - 3495S
  • [6] EGFR mediates LPA-induced proteolytic enzyme expression and ovarian cancer invasion: Inhibition by resveratrol (vol 7, pg 121, 2012)
    Jeong, K. J.
    Cho, K. H.
    Panupinthu, N.
    Kim, H.
    Kang, J.
    Park, C. G.
    Mills, G. B.
    Lee, H. Y.
    [J]. MOLECULAR ONCOLOGY, 2019, 13 (06) : 1462 - 1464
  • [7] Osteopontin is a modulator of lysophosphatidic acid-induced Matrigel invasion in ovarian cancer cells
    Ariztia, E. V.
    Fishman, D. A.
    [J]. GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S62 - S62
  • [8] Resveratrol inhibits lysophosphatidic acid-induced ovarian cancer cell migration
    Lee, HyunWoo
    Park, Soon Young
    Jeong, Kang Jin
    Bae, Narkhyun
    Hong, Sung Yuel
    Lee, Hoi Young
    Han, JeungWhan
    [J]. CLINICAL & EXPERIMENTAL METASTASIS, 2009, 26 (07) : 860 - 860
  • [9] Inhibition of matrilysin expression by antisense or RNA interference decreases lysophosphatidic acid-induced epithelial ovarian cancer invasion
    Wang, Feng-qiang
    Smicun, Yoel
    Calluzzo, Nicholas
    Fishman, David A.
    [J]. MOLECULAR CANCER RESEARCH, 2006, 4 (11) : 831 - 841
  • [10] Alendronate inhibits lysophosphatidic acid-induced migration of human ovarian cancer cells by attenuating the activation of Rho
    Sawada, K
    Morishige, K
    Tahara, M
    Kawagishi, R
    Ikebuchi, Y
    Tasaka, K
    Murata, Y
    [J]. CANCER RESEARCH, 2002, 62 (21) : 6015 - 6020